Vaccinating adolescents against SARS-CoV-2 in England: a risk-benefit analysis.

Deepti GurdasaniSamir BhattAnthony CostelloSpiros DenaxasSeth FlaxmanTrisha GreenhalghStephen GriffinZoë HydeAris KatzourakisMartin MckeeSusan MichieOliver RatmannStephen ReicherGabriel ScallyChristopher TomlinsonChristian YatesHisham ZiauddeenChristina Pagel

Published in: Journal of the Royal Society of Medicine (2021)

Given the current (as at 15 September 2021) high case rates (680/100,000 population/week in 10-19 year olds) in England, our findings support vaccination of adolescents against SARS-CoV2.

Keyphrases

sars cov
young adults
physical activity
respiratory syndrome coronavirus
randomized controlled trial
study protocol